1887

Abstract

The purpose of this study was to compare the frequency of recovery of aerobic and anaerobic organisms with interfering capability against group A -haemolytic streptococci (GABHS) and -lactamase-producing bacteria (BLPB) from the tonsils of GABHS carriers and non-carriers. The presence of aerobic and anaerobic bacteria capable of such interference was evaluated in cultures obtained from the tonsils of 20 healthy children who were non-GABHS carriers and 20 who were GABHS carriers, and also from 20 children who were asymptomatic after completing a course of penicillin for acute GABHS pharyngo-tonsillitis (PT) and were non-GABHS carriers and 20 who were GABHS carriers. In healthy children, 32 interfering isolates were recovered from 16 non-GABHS carriers (1.6 per child) and 13 were isolated from 7 GABHS carriers (0.65 per child) (<0.001). In children who had suffered acute GABHS PT, 26 interfering organisms were recovered from 15 non-GABHS carriers (1.3 per child) and 8 were isolated from 5 GABHS carriers (0.4 per child) (<0.005). In healthy children, 13 BLPB were recovered from 5 non-GABHS carriers and 13 were isolated from 6 GABHS carriers. In children who had suffered acute GABHS PT, 14 BLPB were recovered from 5 (25 %) non-GABHS carriers and 32 were isolated from 17 (85 %) GABHS carriers (<0.05). It was demonstrated in this study that there was a higher rate of recovery of aerobic and anaerobic organisms capable of interfering with GABHS in non-GABHS carriers than in GABHS carriers. This was observed in all GABHS non-carriers and included healthy children as well as those recently treated for symptomatic GABHS PT with penicillin that failed to eradicate GABHS. A higher rate of recovery of BLPB was observed only in GABHS carriers who were treated with penicillin for GABHS PT.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46796-0
2006-12-01
2021-10-26
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1741.html?itemId=/content/journal/jmm/10.1099/jmm.0.46796-0&mimeType=html&fmt=ahah

References

  1. Bisno A. L. 1991; Group A streptococcal infections and acute rheumatic fever. N Engl J Med 325:783–793 [CrossRef]
    [Google Scholar]
  2. Brook I. 1984; The role of β -lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 6:601–607 [CrossRef]
    [Google Scholar]
  3. Brook I. 2001; The role of β -lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 17:439–442 [CrossRef]
    [Google Scholar]
  4. Brook I. 2005; The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg 133:139–146 [CrossRef]
    [Google Scholar]
  5. Brook I., Foote P. A. 2005; Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora. Antimicrob Agents Chemother 49:4787–4788 [CrossRef]
    [Google Scholar]
  6. Brook I., Gober A. E. 1995; Role of bacterial interference and β -lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 121:1405–1409 [CrossRef]
    [Google Scholar]
  7. Brook I., Gober A. E. 1999; Interference by aerobic and anaerobic bacteria in children with recurrent group A β -hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg 125:552–554 [CrossRef]
    [Google Scholar]
  8. Casey J. R., Pichichero M. E. 2004; Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 113:866–882 [CrossRef]
    [Google Scholar]
  9. Cockerill F. R. III, MacDonald K. L., Thompson R. L. and 11 other authors; 1997; An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277:38–43 [CrossRef]
    [Google Scholar]
  10. Crowe C. C., Sanders E., Longley S. 1973; Bacterial interference, II: the role of the normal throat flora in prevention of colonization by group A streptococcus. J Infect Dis 128:527–532 [CrossRef]
    [Google Scholar]
  11. Finegold S. M., Sutter V. 1976; Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother 10:736–752 [CrossRef]
    [Google Scholar]
  12. Grahn E., Holm S. E., Ekedahl C., Roos K. 1983; Interference of α -hemolytic streptococci isolated from tonsillar surface on β -hemolytic streptococci ( Streptococcus pyogenes ) – a methodological study. Zentralbl Bakteriol Mikrobiol Hyg A 254:459–468
    [Google Scholar]
  13. Murray P. R., Baron E. J., Jorgensen J. H., Pfaller M. A., Yolken R. H. 2003 Manual of Clinical Microbiology , 8th edn. Washington DC: American Society for Microbiology;
    [Google Scholar]
  14. O'Brien K. L., Beall B., Barrett N. L. and 8 other authors 2002; Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35:268–276 [CrossRef]
    [Google Scholar]
  15. Pichichero M. E., Marsocci S. M., Lynd Murphy A. M., Hoeger W. 1999; Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 153:624–628 [CrossRef]
    [Google Scholar]
  16. Roos K., Holm E., Grahn-Hakansson E., Lagergren L. 1996; Recolonization with selected α -streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicenter study. Scand J Infect Dis 28:459–462 [CrossRef]
    [Google Scholar]
  17. Summanen P., Baron E. J., Citron D. M., Strong C. A., Wexler H. M., Finegold S. M. 1995 Wadsworth Anaerobic Bacteriology Manual , 5th edn. Belmont, CA: Star Publishing;
    [Google Scholar]
  18. Tanz R. R., Shulman S. T., Barthel M. J., Willert C., Yogev R. 1985; Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 106:876–880 [CrossRef]
    [Google Scholar]
  19. Tanz R. R., Poncher J. R., Corydon K. E., Kabat K., Yogev R., Shulman S. T. 1991; Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 119:123–128 [CrossRef]
    [Google Scholar]
  20. Walls T., Power D., Tagg J. 2003; Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?. J Med Microbiol 52:829–833 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46796-0
Loading
/content/journal/jmm/10.1099/jmm.0.46796-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error